🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

BioMarin Pharmaceutical Inc.

BMRN Healthcare
$69.33 +$2.34 (3.49%)
Market Cap: $13.42 B
Gurus Holding
10
Popularity Rank
#435
% of Shares Held
7.77%
Net Activity (Q2 2026)
-$159.65 M

Guru Ownership Trend

Guru Analysis for BioMarin Pharmaceutical Inc. (BMRN)

BioMarin Pharmaceutical Inc. (BMRN), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 10 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.04 B.

Top institutional holders include Andreas Halvorsen and Cliff Asness.

Institutional sentiment is currently Bearish. This is evidenced by a $159.65 M net outflow during the quarter.

Recent activity highlights HOTCHKIS & WILEY who opened a new position. Conversely, Joel Greenblatt reduced exposure by 83.6%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$61.21 M
Total Buy Value
New Buys 1
Additions 2
-$220.85 M
Total Sell Value
Reductions 6
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
7
Net Buyers
3

FAQs for BioMarin Pharmaceutical Inc. (BMRN)

Major holders include Andreas Halvorsen ($435.82 M), Cliff Asness ($322.54 M), Jefferies Group ($26.68 M). According to the latest reported data, 10 tracked investment managers collectively hold approximately 15.03 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $159.65 M, with 3 managers increasing positions and 7 managers reducing holdings.

During the most recent reporting period, 6 managers trimmed their positions, while 1 fully exited BMRN. The total reported sell value was $220.85 M.

Yes, 1 managers opened new positions in BMRN, and 2 increased their existing holdings. The total reported buy value was $61.21 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
1.24% Add 7.9% 7,616,563 $435.82 M Q2 2026
0.11% Reduce -25.8% 5,699,541 $322.54 M Q2 2026
0.18% Reduce -0.4% 466,258 $26.68 M Q2 2026
0.04% Reduce -55.9% 451,871 $25.86 M Q2 2026
0.07% New Buy 447,200 $25.59 M Q2 2026
0.06% Add 32.9% 274,911 $15.73 M Q2 2026
0.00% Reduce -0.3% 35,389 $2.02 M Q2 2026
0.00% Reduce -83.6% 28,641 $1.64 M Q2 2026
0.01% Reduce -1.1% 13,000 $743,860 Q2 2026
0.00% 170 $9,727 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form